Questions: Metabolic Integration: Coordinating Pathways

Question 1

A skeletal muscle cell is working at maximum capacity during intense exercise, rapidly consuming ATP. Which combination of metabolic effects would you expect in this high-energy-demand state?

• A. Phosphofructokinase-1 inhibited; isocitrate dehydrogenase inhibited; fatty acid synthesis activated
• B. Phosphofructokinase-1 activated; isocitrate dehydrogenase activated; fatty acid synthesis inhibited
• C. Glycolysis inhibited; Krebs cycle inhibited; anabolic pathways fully activated
• D. Phosphofructokinase-1 inhibited; fatty acid synthesis activated; gluconeogenesis stimulated

Answer: (B)

During intense exercise, ATP is consumed rapidly and AMP rises. Low energy charge activates key catabolic enzymes: PFK-1 in glycolysis is allosterically activated by AMP (and inhibited by ATP), and isocitrate dehydrogenase in the Krebs cycle is activated by ADP/AMP and NADH depletion. Simultaneously, high energy demand inhibits fatty acid synthesis and other anabolic pathways that consume ATP. This is the dimmer in action — catabolism accelerates and anabolism slows in proportion to the energy deficit.

Question 2

A genetic defect completely blocks fatty acid oxidation (beta-oxidation). Which cascade of secondary metabolic effects would most likely follow?

• A. Glucose oxidation decreases as the cell compensates by sparing glucose
• B. The Krebs cycle runs faster because more acetyl-CoA from glucose metabolism is redirected into it
• C. Acetyl-CoA accumulates, backing up into ketone body overproduction; the Krebs cycle is starved of substrate; glycogen stores are depleted prematurely as the cell compensates with excess glucose catabolism
• D. Only fat-derived energy is lost; glucose and amino acid metabolism proceed entirely normally

Answer: (C)

This question tests whether students understand that metabolic pathways are interconnected, not modular. Blocking fatty acid oxidation prevents fat-derived acetyl-CoA from entering the Krebs cycle — so the cell must rely more heavily on glucose, depleting glycogen. Without beta-oxidation as a relief valve, fatty acyl-CoA accumulates and backs up into ketone body overproduction. Intermediates pile up in one pathway and are diverted into others, causing cascading imbalances across the network.

Question 3

When cellular ATP and NADH levels are high, both phosphofructokinase-1 (glycolysis) and isocitrate dehydrogenase (Krebs cycle) are allosterically inhibited.

• T. True
• F. False

Answer: True

High energy charge signals 'enough energy — slow down fuel burning.' PFK-1 is inhibited by ATP and activated by AMP; isocitrate dehydrogenase is inhibited by high NADH and ATP. This coordinated inhibition slows both the glycolytic input and the Krebs cycle processing simultaneously, preventing excess catabolism when the cell doesn't need more ATP. The same logic applies to other rate-limiting enzymes across catabolic pathways.

Question 4

Cellular metabolic regulation works like a binary on/off switch: either catabolic pathways are fully active or anabolic pathways are fully active, depending on energy status.

• T. True
• F. False

Answer: False

Metabolic regulation operates as a continuous dimmer, not an on/off switch. Dozens of enzymes with overlapping allosteric sensitivities respond proportionally to energy charge. At intermediate ATP/AMP ratios, both catabolism and anabolism proceed simultaneously at intermediate rates. This graded response allows cells to fine-tune flux through each pathway in real time, which is essential for maintaining homeostasis across a wide range of conditions.

Question 5

How do shared hub intermediates like pyruvate and acetyl-CoA enable coordinated regulation of multiple metabolic pathways simultaneously?

Model answer: Hub intermediates connect multiple pathways at a single decision point. Pyruvate, produced by glycolysis, can be routed to acetyl-CoA (oxidation), oxaloacetate (anaplerosis), lactate (anaerobic regeneration of NAD+), or alanine (amino acid synthesis). Which route predominates depends on the cell's energy charge and biosynthetic needs. Because all these routes converge on one molecule, altering conditions at the hub instantly shifts flux across all connected pathways — no separate signal is needed for each one.

This is the key architectural insight: metabolic integration doesn't require a central controller signaling each pathway independently. Instead, shared intermediates act as real-time sensors and routers. When acetyl-CoA accumulates (because the Krebs cycle is slowed by high NADH), it allosterically inhibits pyruvate dehydrogenase, slowing its own production — a built-in feedback loop. This hub architecture means one biochemical change propagates automatically through the network, explaining why metabolic diseases have such wide-ranging effects.